Innovent Biologics Inc (1801.HK)
Company Info
| ISIN | KYG4818G1010 |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | HK$55.85B |
|---|---|
| EPS | HK$0.00 |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue (TTM) | HK$4.56B |
| Gross Profit (TTM) | HK$3.17B |
| EBITDA (TTM) | -HK$2.88B |
| Year Range | HK$21.20 - HK$47.95 |
| Target Price | HK$51.22 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of HK$10,000 in Innovent Biologics Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Innovent Biologics Inc had a return of 8.66% year-to-date (YTD) and 49.79% in the last 12 months. Over the past 10 years, Innovent Biologics Inc had an annualized return of 19.21%, outperforming the S&P 500 benchmark which had an annualized return of 9.49%.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | 0.14% | 0.91% |
| Year-To-Date | 8.66% | 7.82% |
| 6 months | 22.77% | 2.41% |
| 1 year | 49.79% | -2.53% |
| 5 years (annualized) | 19.21% | 9.49% |
| 10 years (annualized) | 19.21% | 9.49% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 26.72% | -10.25% | -7.74% | 6.54% | -2.00% | |||||||
| 2022 | 10.25% | 9.30% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Innovent Biologics Inc (1801.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
1801.HK Innovent Biologics Inc | 1.14 | ||||
^GSPC S&P 500 | 0.10 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Innovent Biologics Inc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Innovent Biologics Inc is 82.01%, recorded on May 13, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -82.01% | Jan 21, 2021 | 321 | May 13, 2022 | — | — | — |
| -30.43% | Feb 28, 2020 | 12 | Mar 16, 2020 | 28 | Apr 27, 2020 | 40 |
| -27.62% | Mar 20, 2019 | 47 | May 30, 2019 | 157 | Jan 15, 2020 | 204 |
| -24.72% | Oct 23, 2020 | 23 | Nov 25, 2020 | 16 | Dec 17, 2020 | 39 |
| -22.97% | Jul 10, 2020 | 24 | Aug 12, 2020 | 24 | Sep 15, 2020 | 48 |
Volatility Chart
The current Innovent Biologics Inc volatility is 16.15%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.